Epigenetics in liver disease

Mann, Derek A.·2014·Hepatology
DOI 10.1002/hep.27131

Cited by (152)

Items 101–152 of 152

  1. Molecular epigenetic targets for liver diseases: current challenges and future prospects
    Robert B. Zeidler, Bruno Freitas, Augustinus Bader, Shibashish Giri · 2017 · Drug Discovery Today
  2. Dual Effect of IL-6 -174 G/C Polymorphism and Promoter Methylation in the Risk of Coronary Artery Disease Among South Indians
    Bobbala Indumathi, Shiva Krishna Katkam, L.S.R. Krishna, Vijay Kumar Kutala · 2018 · Indian Journal of Clinical Biochemistry
  3. LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling
    Xianghong Xie, Mingyue Gao, Wei Guang Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo et al. · 2024 · eLife
  4. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis
    Albert J. Czaja · 2022 · Expert Review of Clinical Immunology
  5. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact
    Ziyan Pan, Wai‐Kay Seto, Chun‐Jen Liu, Yilei Mao, Saleh A. Alqahtani, Mohammed Eslam · 2024 · HepatoBiliary Surgery and Nutrition
  6. Serum miR-21 correlates with the histological stage of chronic hepatitis B-associated liver fibrosis.
    Hsien-Chih Wu, Chia-Lin Huang, Hung‐Wei Wang, Wei‐Fan Hsu, Tsung-Yu Tsai, Sheng‐Hung Chen, Cheng‐Yuan Peng · 2019 · Europe PMC (PubMed Central)
  7. Missing Causality and Heritability of Autoimmune Hepatitis
    Albert J. Czaja · 2022 · Digestive Diseases and Sciences
  8. ER stress upregulates S100A11 in steatohepatitis models via epigenetic modifications within the lipotoxicity-influenced enhancer
    P. Vineeth Daniel, Hanna L. Erickson, Daheui Choi, Feda H. Hamdan, Yasuhiko Nakao, Gyanendra Puri, Takahito Nishihara, Y YOON, Amy S. Mauer, Debanjali Dasgupta et al. · 2025 · Journal of Clinical Investigation
  9. Liver epigenomic signature associated with chronic oxidative stress in a mouse model of glutathione deficiency
    Seong Hwi Hong, Xiaoqing Yu, Yong Zhu, Ying Chen · 2024 · Chemico-Biological Interactions
  10. Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2′-deoxycytidine in Hepatic Stellate Cells
    Kiyoshi Asada, Kosuke Kaji, Shinya Sato, Kenichiro Seki, Naotaka Shimozato, Hideto Kawaratani, Hiroaki Takaya, Yasuhiko Sawada, Keisuke Nakanishi, Masanori Furukawa et al. · 2020 · Biology
  11. Towards a reference cell atlas of liver diversity over the human lifespan
    Sarah A. Taylor, Gary D. Bader, Sonya A. MacParland, Alan C. Mullen, Tallulah S. Andrews, Alex G. Cuenca, Ramanuj DasGupta, Adam J. Gehring, Dominic Grün, Martin Guilliams et al. · 2025 · Nature Reviews Gastroenterology & Hepatology
  12. Histone O-GlcNAcylation and Potential Biological Functions
    Mitsuko Hirosawa, Koji Hayakawa, Kunio Shiota, Satoshi Tanaka · 2018 · OBM Genetics
  13. Chronopharmacological Characteristics of the Effect of Hepatoprotectors in Experiment?
    N. D. Bunyatyan, К. О. Каlko, С. М. Дроговоз, А. В. Кононенко · 2018 · Bulletin of Experimental Biology and Medicine
  14. Inhibition of Dot1L Alleviates Fulminant Hepatitis Through Myeloid-Derived Suppressor Cells
    Wanlin Yang, Hongshuang Yu, Jiefang Huang, Xiang Miao, Qiwei Wang, Yanan Wang, Yiji Cheng, Shan He, Fang Zhao, Lijun Meng et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  15. Age-dependent changes in extracellular matrix turnover: An under evaluated issue in the approach to chronic liver diseases
    Maurizio Parola · 2015 · Journal of Hepatology
  16. Downregulation of HDAC9 Alleviates Autophagy Dysfunction by Inducing Acetylation of ATG4B in Metabolic Dysfunction‐Associated Steatotic Liver Disease
    Xiao‐Han Ma, G. Liu, Le Liu, Zhuli Dou, Xue Mei He, Xi Chen · 2025 · The FASEB Journal
  17. Structure and Function of Hepatic Parenchymal Cells
    Sachin S. Devi · 2017 · Elsevier eBooks
  18. Nanodelivery of panobinostat induces cell cycle arrest and apoptosis to suppress hepatocellular carcinoma growth in mice
    Yutong Li, Dong Li, Junjun Chen, Yuqiong Gao, Xingze Zou, Huan Li, Zhuo Yu, Yifang Zou, Jianfeng Guo · 2025 · Materials Today Bio
  19. Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
    Michael Adisasmita, Hyomin K. Lee, Yohan An, Myounghoi Kim, Michael Girma Mamo, Junho K. Hur, Dongho Choi, Ji Hyun Shin, Yun Kyung Jung · 2024 · Annals of Surgical Treatment and Research
  20. Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis
    Albert J. Czaja · 2024 · Expert Review of Gastroenterology & Hepatology
  21. Chromatin Remodeling and Epigenetic Reprogramming in Chronic Disease and Cancer in the Liver and Pancreas
    Maite G. Fernández‐Barrena, Christopher L. Pin · 2016 · Elsevier eBooks
  22. Looking Beyond Sorafenib to Treat Advanced Hepatocellular Carcinoma
    Swastik Agrawal · 2016 · Journal of Clinical and Experimental Hepatology
  23. Next-Generation Sequencing in Paediatric Hepatology
    Lorenzo D’Antiga · 2019 · Springer eBooks
  24. Genetic and environmental reprogramming of the sarcoma epigenome
    Anne Grand’Maison, Rachael Kohrn, Emmanuel B. Omole, Mahek Shah, Peter N. Fiorica, Jennie Sims, Joyce Ellen Ohm · 2022 · Advances in pharmacology
  25. Vitamin B Regulation of Alcoholic Liver Disease
    Charles H. Halsted, Valentina Medici · 2015 · Elsevier eBooks
  26. Epigenetic Regulation of Intestinal Fibrosis
    Chao Li, John F. Kuemmerle · 2018 · Springer eBooks
  27. Noncoding RNAs: A Novel Frontier in Liver Cancer Research and Therapy: Implications for Precision Oncology
    Al-Aliaa M. Sallam, Mahmoud A. Elrebehy, Ibrahim M. Elazab, Mohamed S. Elballal, Ola E. Elazazy, Samah S. Abbas, Manar Mohammed El Tabaa, Shih‐Min Hsia, Miguel Á. Chávez‐Fumagalli, Nadia Μ. Hamdy · 2026 · Sub-cellular biochemistry/Subcellular biochemistry
  28. Personalized Medicine and Epigenetic Drug Development
    Kenneth H. Lundstrom · 2015 · Elsevier eBooks
  29. Epigenetics And Nutrition
    Kenneth H. Lundstrom · 2015 · International Journal Of Nutrition
  30. Autoimmune Hepatitis and Immune-Mediated Cholestatic Liver Diseases
    Albert J. Czaja · 2018 · Springer eBooks
  31. Autoimmune Liver Disease
    Giorgina Mieli‐Vergani, Diego Vergani · 2019 · Springer eBooks
  32. Hypomethylation of Thyroid Peroxidase as a Biomarker for Hepatocellular Carcinoma with Tumor Thrombosis
    Ruting Xie, Qianyu Li, Xuechen Sun, Qing-jun Zhi, Xiangxiang Huang, Xingchen Zhu, Qi-zeng Miao, Daizhan Zhou, Dongyan Han · 2022 · Current Medical Science
  33. Circadian peculiarities of antioxidant and membrane-protective properties of glutargin in acute chrono-determined paracetamol-induced hepatitis
    К. О. Каlko, С. М. Дроговоз, О. О. Kоyro, A. Yu. Pozdniakova · 2017 · Clinical pharmacy
  34. WITHDRAWN: Epigenetics in Chronic Liver Disease
    Marie Boyle, Jelena Mann · 2017 · Journal of Hepatology · Retracted
  35. The Difference Analysis of Histone Modifications in Cancer Cell Line HepG2 and Normal Cell Line Hepatocyte
    育仙 刘 · 2018 · Hans Journal of Computational Biology
  36. Epigenetic Mechanisms Regulating the Functional Effects of Chronic Alcohol Exposure of Human Monocyte-derived Dendritic Cells
    Tiyash Parira · 2018
  37. Host Genetic Characters of Acute Exacerbation of Chronic Hepatitis B (AECHB)
    Yuming Wang, Junqi Niu, Guohong Deng, Yingren Zhao · 2019 · Springer eBooks
  38. Liver fibrogenesis
    Diana Vetter, Scott L. Friedman · 2017 · Elsevier eBooks
  39. The Art of Mesenchymal Stem Cells in Liver Fibrosis Management
    Farid Amansyah, Dito Anurogo · 2021 · Bioinformatics and Biomedical Research Journal
  40. Autoimmunity of the liver
    Angelo Armandi, Giovanni Clemente Actis, Davide Giuseppe Ribaldone · 2022 · Elsevier eBooks
  41. Epigenetic modifications and regulations in gastrointestinal diseases
    Aditi Bhattacharya · 2023 · Elsevier eBooks
  42. LncRNA-Snhg3 Aggravates Hepatic Steatosis by Regulating PPARγ via SND1/H3K27me3
    Xianghong Xie, Mingyue Gao, Wei Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo et al. · 2024 · eLife
  43. Personalized medicine and epigenetic drug development
    Kenneth H. Lundstrom · 2024 · Elsevier eBooks
  44. LncRNA Snhg3 Aggravates Hepatic Steatosis via PPARγ Signaling
    Xianghong Xie, Mingyue Gao, Wei Guang Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo et al. · 2024 · eLife
  45. LncRNA Snhg3 Aggravates Hepatic Steatosis via PPARγ Signaling
    Xianghong Xie, Mingyue Gao, Wei Guang Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo et al. · 2024 · eLife
  46. Recent research advances in RNA m5C methylation modification in liver diseases
    Wenjuan Chen, Lifan Zhang, Xinyu Gu, Yafeng Liu, Shujun Zhang, Xinjun Hu, Penghui Li · 2025 · Frontiers in Molecular Biosciences
  47. PATHOGENETIC AND MOLECULAR MECHANISMS OF CHRONIC STRESS-INDUCED LIVER DAMAGE: FROM THE HPA AXIS TO CIRRHOSIS
    V. Petrushenko, D. I. Grebeniuk, Serhii A. Sidorov · 2026 · Reports of Vinnytsia National Medical University
  48. Epigenetic Regulation of Liver Fibrosis: Mechanisms and Therapeutic Implications
    Maryam Jadid Tavaf, Mahboobeh Ebrahimi Varkiani, Saeid Abroun, Pedram Asadi Sarabi, Shukoofeh Torabi, Elham Rismani, Mohammad Majd Hammour, Andreas Klaus Nussler, Massoud Vosough · 2026 · Portal hypertension & cirrhosis
  49. Epigenomic Cascades Across Organs in Metabolic Dysfunction–Associated Steatotic Liver Disease: New Therapeutic Horizons
    S. Yang, Zhongyu Huang, Sanchun Tan, Fengxia Liang, Li Chen · 2026 · Obesity Reviews
  50. Intravital Imaging as a Tool to Uncover Roles of Immune Cells in Chronic Liver Diseases
    Mahamud‐ur Rashid, Woo‐Yong Lee, Paul Kubes · 2026 · JHEP Reports
  51. Epigenetic signatures associated with the hepatic exposome in NAFLD and NASH: an exploratory cross-sectional study of circulating and PBMC-based biomarkers
    Maytham Khazaal Kadhim · 2026 · Journal of Liver Transplantation
  52. Chromatin remodeling and epigenetic reprogramming in chronic disease and cancer in the liver and pancreas
    Ateka Saleh, Karam Ghazal‐Aswad, M.G. Fernandez-Barrena, C.L. Pin · 2026 · Elsevier eBooks